Skip to content

Wellcome

Bioimaging Technology Development Awards

Foundation phase: up to £500k; Scale-up phase: resources as neededUp to 8 years (foundation phase: 1.5 years; scale-up phase: up to 6.5 additional years)

One-off call; no specific deadline stated in this segment

Last verified:

Is this grant right for you? Check your personalised match score. 30s, no email. See my matches →

The Wellcome Bioimaging Technology Development Awards fund novel cell-tissue scale imaging technology development through a two-phase model: a foundation phase (up to £500k, 1.5 years) followed by an invited scale-up phase (up to 6.5 additional years, resources as needed). Applicants must assemble a 3-5 person consortium led by a researcher at a UK, Irish, or low/middle-income country institution, with the lead committing ≥20% research time on a permanent contract. This is a one-off call aimed at building interdisciplinary teams that translate early-stage imaging concepts into real-world tools.

Details

Funder Wellcome
Budget Foundation phase: up to £500k; Scale-up phase: resources as needed
Duration Up to 8 years (foundation phase: 1.5 years; scale-up phase: up to 6.5 additional years)
Consortium Required — 3–5 applicants (lead + coapplicants) at application; up to 8 for scale-up phase
Application 2-stage: foundation phase application → scale-up phase application (invited, 12 months into foundation phase)
Frequency One-off
Eligible countries GBIE

Eligibility & scope

Lead applicant must be based at a not-for-profit organisation in the UK, Republic of Ireland, or a low/middle-income country (excl. India and mainland China). Teams of 3–5 applicants required; coapplicants can be worldwide except mainland China. Supports novel bioimaging technology development at cell-tissue scale. Lead must contribute ≥20% research time and hold a permanent/open-ended contract. UK/Ireland leads cannot claim salary.

Who Should Apply

  • Lead applicants on a permanent or open-ended contract at a UK, Irish, or eligible low/middle-income country not-for-profit institution
  • Researchers able to commit ≥20% of their time to the project over its duration
  • Interdisciplinary teams of 3-5 investigators (lead + coapplicants) with complementary expertise in imaging, engineering, biology, and/or clinical translation
  • Applicants with a novel, cell-tissue scale bioimaging technology ready to move from concept toward practical implementation
  • Teams including coapplicants from worldwide institutions (except mainland China)

Key Dates

  • One-off call; no specific deadline stated
  • Two-stage evaluation: foundation phase application → scale-up phase application (invited at 12 months into foundation phase)
  • Up to 8 years total (foundation phase 1.5 years; scale-up phase up to 6.5 additional years)

Tips for Applicants

  • Assemble your consortium before writing, Wellcome weights team composition and fit heavily; a weak coapplicant damages the bid.
  • The foundation phase is a proof-of-concept stage; focus on demonstrating technical feasibility and user validation, not scale. Save scaling plans for the scale-up phase application.
  • Lead applicants at UK/Ireland institutions cannot claim personal salary; budget the £500k foundation award for equipment, postdoctoral support, and coapplicant contributions instead.

Frequently Asked Questions

What is the budget for the Wellcome Bioimaging Technology Development Awards?

Foundation phase awards up to £500,000 over 1.5 years; scale-up phase funding is determined on a case-by-case basis and is not capped.

Who can be the lead applicant?

A researcher on a permanent or open-ended contract at a not-for-profit organisation in the UK, Republic of Ireland, or an eligible low/middle-income country (excluding India and mainland China).

Is this a recurring call?

No, this is a one-off call with no specific deadline stated; researchers should monitor the Wellcome website for call opening and closing dates.

Must the team be assembled at application?

Yes, the lead applicant must propose a consortium of 3-5 investigators at the time of the foundation phase application; coapplicants can be based anywhere except mainland China.

What happens after the foundation phase?

Successful foundation phase teams are automatically invited to submit a scale-up phase application at 12 months into the foundation phase; scale-up can extend the project to up to 8 years total.

bioimagingwellcometechnology-developmentconsortium-requiredtranslational-researchuk-irelandcell-tissue-imaging

Related on Grantsby

Summary generated by AI based on published grant information. Always verify details on the funder's website.

More from Wellcome

Browse all open grants →

Browse Related

Could Bioimaging Technology Development Awards be right for you?

See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.

See my matches free →